Chris Burns
Tracked across 1 events · 8 articles · First seen May 09, 2026 · Last active May 09, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: Dr. Chris Burns is the CEO and Managing Director of Amplia Therapeutics and expressed satisfaction with the collaboration, highlighting the potential of FAK inhibitors in ovarian cancer.
May 09, 2026 · 8 articles
ERGEN INTELLIGENCE
Track Chris Burns live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard